SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-013717
Filing Date
2023-04-26
Accepted
2023-04-26 17:27:37
Documents
12
Period of Report
2022-12-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 60730
  Complete submission text file 0001493152-23-013717.txt   234404

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mrzm-20221227.xsd EX-101.SCH 3227
3 XBRL LABEL FILE mrzm-20221227_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mrzm-20221227_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3500
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-53223 | Film No.: 23850948
SIC: 2834 Pharmaceutical Preparations